返回
M
Matthew E. Falagas
alfa institute of biomedical sciences
125H指数
974论文数
6.7W被引数
收录论文 375
发表时间
Antibiotics and non-traditional antimicrobial agents for Pseudomonas aeruginosa in clinical phases 1, 2, and 3 trialsRomanos, L.T.; Kontogiannis, D.S.; Tsiampali, C.; Tzvetanova, I.D.; Falagas, M.E. 抗生素和非传统抗菌剂对铜绿假单胞菌在临床I、II和III期试验中的应用。Expert Opin. Investig. Drugs 2025, 25, 32443. [Google Scholar] [CrossRef] [PubMed]
Risk factors for colistin-resistant, extensively drug-resistant (XDR) and pandrug-resistant (PDR) Acinetobacter baumannii infections: a reviewVrysis, C.; Kontogiannis, D.S.; Ntourakis, D.; Kakoullis, S.A.; Falagas, M.E. 鲍曼不动杆菌对粘菌素耐药、广泛耐药(XDR)和全耐药(PDR)感染的危险因素:一篇综述. 专家评论. 抗感染治疗. 2025, 1–13. [谷歌学术] [交叉引用] [PubMed]

